Literature DB >> 16214970

The peripherally inserted central catheter: what are the current indications for its use?

Marsha Evans Orr1.   

Abstract

The use of peripherally inserted central catheters (PICCs) has dramatically increased since first being used for IV therapy in the 1980s. Currently, sales of PICCs are second only to acute care central venous catheters and exceed all other types of long-term venous access devices. The use of PICCs has also increased dramatically in the home care setting. A number of studies have examined the incidence of PICC complications in comparison to other central venous access devices. Although complications differ, most reports have concluded that the type and rate of PICC complications compare favorably with other access devices in the short-term; however, dwell times beyond a few weeks have been associated with decreased complication-free days and lower device survivability rates. The PICC seems to be most appropriate for acute care or short-term home care use and may not be the ideal central venous access device when the need for long-term access is anticipated.

Year:  2002        PMID: 16214970     DOI: 10.1177/011542650201700299

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  3 in total

Review 1.  Peripherally inserted central venous catheters are not superior to central venous catheters in the acute care of surgical patients on the ward.

Authors:  Simon Turcotte; Serge Dubé; Gilles Beauchamp
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

2.  Peripherally inserted central catheters in non-hospitalized cancer patients: 5-year results of a prospective study.

Authors:  Paolo Cotogni; Cristina Barbero; Cristina Garrino; Claudia Degiorgis; Baudolino Mussa; Antonella De Francesco; Mauro Pittiruti
Journal:  Support Care Cancer       Date:  2014-08-14       Impact factor: 3.603

3.  Clinical outcome of long-term home parenteral nutrition in non-oncological patients: a report from two specialised centres.

Authors:  R Bonifacio; L Alfonsi; L Santarpia; A Orban; A Celona; G Negro; F Pasanisi; F Contaldo
Journal:  Intern Emerg Med       Date:  2007-10-03       Impact factor: 5.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.